Literature DB >> 20477947

Gi protein coupling to adenosine A1-A2A receptor heteromers in human brain caudate nucleus.

Vicent Casadó1, Sergio Barrondo, Milena Spasic, Luis F Callado, Josefa Mallol, Enric Canela, Carmen Lluís, Javier Meana, Antoni Cortés, Joan Sallés, Rafael Franco.   

Abstract

Pharmacological characterization of adenosine A(1) and A(2A) receptors in human brain caudate nucleus membranes led to non-cooperative binding of radiolabelled ligands. In human caudate nucleus but not in cortex, the agonist binding to A(1) receptors was modulated by the agonist binding to A(2A) receptors indicating a functional negative cross-talk. Accordingly, the A(1) receptor-activation-mediated G(i)-dependent guanosine 5'-o-(3-[(35)S]thio-triphosphate) binding was modulated by agonist binding to A(2A) receptors. A(2A) receptors occupation led to a decrease in the potency of A(1) receptor agonists. These results indicate that A(1) but not A(2A) receptors activation, likely occurring at low adenosine concentrations, engages a G(i)-mediated signaling; however, when both receptors are occupied by adenosine, there is an A(2A) receptor-mediated impairment of G(i)-operated transducing units. These findings are relevant to get insight into the complex relationships derived from co-expression of multiple neurotransmitter/neuromodulator receptors subtypes that individually are coupled to different G proteins. A further finding was the demonstration that the A(2A) receptor agonist, CGS 21680, at high concentrations able to significantly bind to the A(1) receptor, behaved as a partial agonist of the later receptor. This fact might be taken into account when characterizing CGS 21680 actions in human cells expressing A(1) receptors when the compound is used at micromolar concentrations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20477947     DOI: 10.1111/j.1471-4159.2010.06810.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

Review 1.  Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.

Authors:  Nicola J Smith; Graeme Milligan
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Differential effects of adenosine A2a and A2b receptors on cardiac contractility.

Authors:  P Charukeshi Chandrasekera; Victoria J McIntosh; Frank X Cao; Robert D Lasley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-08       Impact factor: 4.733

3.  Functional coupling between adenosine A1 receptors and G-proteins in rat and postmortem human brain membranes determined with conventional guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding or [35S]GTPγS/immunoprecipitation assay.

Authors:  Yuji Odagaki; Masakazu Kinoshita; Toshio Ota; J Javier Meana; Luis F Callado; Isao Matsuoka; Jesús A García-Sevilla
Journal:  Purinergic Signal       Date:  2018-02-28       Impact factor: 3.765

Review 4.  Purinergic signaling in the retina: From development to disease.

Authors:  Ana Lucia Marques Ventura; Alexandre Dos Santos-Rodrigues; Claire H Mitchell; Maria Paula Faillace
Journal:  Brain Res Bull       Date:  2018-11-17       Impact factor: 4.077

5.  Association of adenosine receptor gene polymorphisms and in vivo adenosine A1 receptor binding in the human brain.

Authors:  Christa Hohoff; Valentina Garibotto; David Elmenhorst; Anna Baffa; Tina Kroll; Alana Hoffmann; Kathrin Schwarte; Weiqi Zhang; Volker Arolt; Jürgen Deckert; Andreas Bauer
Journal:  Neuropsychopharmacology       Date:  2014-06-19       Impact factor: 7.853

6.  Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure.

Authors:  Maria H Madeira; Filipe Elvas; Raquel Boia; Francisco Q Gonçalves; Rodrigo A Cunha; António Francisco Ambrósio; Ana Raquel Santiago
Journal:  J Neuroinflammation       Date:  2015-06-10       Impact factor: 8.322

Review 7.  The Interplay between Cancer Biology and the Endocannabinoid System-Significance for Cancer Risk, Prognosis and Response to Treatment.

Authors:  Estefanía Moreno; Milena Cavic; Ana Krivokuca; Enric I Canela
Journal:  Cancers (Basel)       Date:  2020-11-05       Impact factor: 6.639

8.  ADORA2A variation and adenosine A1 receptor availability in the human brain with a focus on anxiety-related brain regions: modulation by ADORA1 variation.

Authors:  Christa Hohoff; Tina Kroll; Baoyuan Zhao; Nicole Kerkenberg; Ilona Lang; Kathrin Schwarte; David Elmenhorst; Eva-Maria Elmenhorst; Daniel Aeschbach; Weiqi Zhang; Bernhard T Baune; Bernd Neumaier; Andreas Bauer; Jürgen Deckert
Journal:  Transl Psychiatry       Date:  2020-11-24       Impact factor: 6.222

9.  Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1.

Authors:  Leyre Echeazarra; Gontzal García Del Caño; Sergio Barrondo; Imanol González-Burguera; Miquel Saumell-Esnaola; Xabier Aretxabala; Maider López de Jesús; Leire Borrega-Román; Susana Mato; Catherine Ledent; Carlos Matute; María Aranzazu Goicolea; Joan Sallés
Journal:  Histochem Cell Biol       Date:  2021-08-27       Impact factor: 4.304

Review 10.  Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization.

Authors:  Stephen J Hill; Lauren T May; Barrie Kellam; Jeanette Woolard
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.